<DOC>
	<DOC>NCT00002101</DOC>
	<brief_summary>To compare the efficacy of clarithromycin/ethambutol with placebo or with rifabutin at two different doses in reducing colony-forming units (CFUs) by 2 or more logarithms in patients with Mycobacterium avium Complex bacteremia and maintaining this response until 16 weeks post-randomization. To assess survival and comparative tolerability among the three treatment regimens.</brief_summary>
	<brief_title>A Three-Arm Comparative Trial for the Treatment of MAC Bacteremia in AIDS: A Clarithromycin/Ethambutol Regimen Containing Rifabutin (450 Mg) or Rifabutin (300 Mg) or Placebo</brief_title>
	<detailed_description>Patients are randomized to receive clarithromycin and ethambutol plus either placebo or rifabutin at one of two doses. Treatment continues indefinitely. AS PER AMENDMENT 04/19/94: Doses of rifabutin have been lowered.</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Bacteremia</mesh_term>
	<mesh_term>Mycobacterium Infections</mesh_term>
	<mesh_term>Mycobacterium avium-intracellulare Infection</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>Ethambutol</mesh_term>
	<mesh_term>Rifabutin</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication: Allowed: Isoniazid for TB prophylaxis ONLY. Patients must have: HIV infection. MAC infection. Life expectancy of at least 16 weeks. Exclusion Criteria Coexisting Condition: Patients with the following symptoms or conditions are excluded: Perceived unreliability or unavailability for frequent monitoring. Concurrent Medication: Excluded: Antimycobacterial drugs other than the study drugs. Carbamazepine. Terfenadine. Theophylline. Patients with the following prior condition are excluded: History of hypersensitivity to rifabutin, rifampin, erythromycin, clarithromycin, azithromycin, or ethambutol. Prior Medication: Excluded within 7 days prior to study entry: Rifabutin. Rifampin. Ethionamide. Cycloserine. Clofazimine. Ethambutol. Amikacin. Ciprofloxacin. Ofloxacin. Sparfloxacin. Azithromycin. Clarithromycin. Pyrazinamide. Excluded within 14 days prior to study entry: Carbamazepine. Terfenadine. Theophylline.</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 1999</verification_date>
	<keyword>Rifabutin</keyword>
	<keyword>Mycobacterium avium-intracellulare Infection</keyword>
	<keyword>Drug Therapy, Combination</keyword>
	<keyword>Ethambutol</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>Clarithromycin</keyword>
</DOC>